Effects of Malnutrition Assessment via PG-SGA on Clinical Outcomes in Patients with Advanced Gastrointestinal Cancers: A Retrospective Cohort Analysis - Scorecard - MDSpire

Effects of Malnutrition Assessment via PG-SGA on Clinical Outcomes in Patients with Advanced Gastrointestinal Cancers: A Retrospective Cohort Analysis

  • By

  • Pei Zhuang

  • Jun-xuan Chen

  • Bing Xia

  • Xiao-su Chen

  • Xiao-tian Chen

  • Li Li

  • Ting Zhu

  • Shu-an Wang

  • Qing-yan Li

  • October 27, 2025

  • 0 min

Share

Clinical Scorecard: Effects of Malnutrition Assessment via PG-SGA on Clinical Outcomes in Patients with Advanced Gastrointestinal Cancers: A Retrospective Cohort Analysis

At a Glance

CategoryDetail
ConditionAdvanced Gastrointestinal Cancers
Key MechanismsMalnutrition as a prognostic modulator affecting treatment tolerance and immune function.
Target PopulationPatients with pathologically confirmed advanced gastrointestinal malignancies.
Care SettingDepartment of Medical Oncology, Jiaxing Second Hospital.

Key Highlights

  • Malnutrition affects 25%-70% of cancer patients, significantly impacting survival.
  • PG-SGA tool effectively assesses malnutrition risk in cancer patients.
  • Intermediate/high malnutrition risk correlates with worse overall survival.
  • Early nutritional intervention can improve 2-year survival rates by 23%.
  • Dynamic nutritional monitoring is essential for optimizing cancer treatment.

Guideline-Based Recommendations

Diagnosis

  • Utilize PG-SGA for assessing malnutrition risk in cancer patients.

Management

  • Implement nutritional interventions based on PG-SGA assessment results.

Monitoring & Follow-up

  • Conduct regular nutritional assessments at 3-month intervals.

Risks

  • Patients with high PG-SGA scores face increased mortality risk.

Patient & Prescribing Data

102 patients with advanced gastrointestinal malignancies.

Management includes palliative and systemic therapies based on clinical guidelines.

Clinical Best Practices

  • Integrate nutritional risk assessment into routine oncology care.
  • Adhere to evidence-based clinical practice guidelines for treatment.

References

Original Source(s)

Related Content